Recent Blog Posts

View Post: mutations of mortality: Alemtuzumab at ASH
17 Nov 2009 by Terry Hamblin  
Alemtuzumab is thought to be a superior monoclonal to rituximab for the treatment of CLL. The question ought then to be asked as to whether FCA would be superior to FCR. In fact the ASH abstracts report just such a trial from France and ...
View Blog: mutations of mortality - http://mutated-unmuated.blogspot.com/

---

View Post: Alemtuzumab drug possible interactions
24 Nov 2009 by SideEffects  
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Some people receiving a alemtuzumab injection have had a reaction to the ...
View Blog: Side Effects Of - http://www.sideeffectsof.me/

---

View Post: Phase II Study of Alemtuzumab in Combination With Pentostatin in ...
6 Nov 2009 by Ravandi, Aribi, O'Brien, Faderl, Jones,...  
Patients and Methods We treated 24 patients with a variety of T-cell leukemias and lymphomas with a combination of alemtuzumab 30 mg intravenously (IV) three times weekly for up to 3 months and pentostatin 4 mg/m2 IV weekly for 4 weeks ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/

---

View Post: Genzyme's Alemtuzumab for Multiple Sclerosis Shows Durable ...
14 Sep 2009
Genzyme's Alemtuzumab for Multiple Sclerosis Shows Durable Treatment Benefit in Review of Four-Year Phase 2 Trial Data, Company's CARE-MS II Phase 3 Trial Completes Enrollment: Genzyme Corporation reported today that four-year follow-up ...
View Blog: Bionity.COM News - http://www.bionity.com/news/e/

---

View Post: Favorable outcomes with alemtuzumab-conditioned unrelated donor ...
30 Sep 2009 by Patel, B., Kirkland, KE, Szydlo, R., Pearce,...  
Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission ...
View Blog: Haematologica current issue - http://www.haematologica.org/

---

View Post: Research Papers, Journals, Pubmed » Immune reconstitution syndrome ...
15 hours ago by Weetman A  
Other reconstitution autoimmune phenomena, including immune thrombocytopaenic purpura, are also recognised after alemtuzumab administration. Finally, reconstitution Graves' disease may occur during a similar phase of CD4(+) T-cell ...
View Blog: Research Papers, Journals, Pubmed - http://pubmeddy.com/

---

View Post: alemtuzumab overdose
6 Sep 2009 by CatherIN  
an overdose may occur if more than the prescribed dose of alemtuzumab is used. signs of an overdose of alemtuzumab may include tightening of the throat, difficulty breathing, cough, decreased urination, unusual bruising or bleeding, ...
View Blog: organizedwisdom Health - Multiple Sclerosis - http://organizedwisdom.com/Category:Multiple_Sclerosis

---

View Post: mutations of mortality: Alemtuzumab at ASH
17 Nov 2009 by Rohan  
Eleven (19%) patients have died: 4 with disease advancement after achieving CR; 2 who did not respond; 2 with Richter's transformation; 1 who developed AML; 1 cod to metastatic lung cancer; and 1 cod to nonindulgent pneumonia 8 months ...
View Blog: Lung cancer metastasis - http://lungcancermetastasis.blogspot.com/

---